A meta-analysis has revealed that risk alleles at the KLF14 gene are associated with reducing the HLD-C level, KLF14 expression in adipose tissues, and increased T2DM risk, which suggested that an increased level of KLF14 has a protective effect against the risk of development and progression of metabolic disorders [10]. Here, KLF14 is linked to metabolic disease.